Publications by authors named "Joseph Franz"

Claim this Profile
P
Persistent cytopenias after anti-BCMA CAR T-cell therapy are associated with reduced hematopoietic activity in posttreatment bone marrows.
Pranav Pramod Patwardhan, Joseph Franz, Mounzer Agha, Bryan Rea

Am J Clin Pathol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure of CAR-T cell therapy in relapsed and refractory large cell lymphoma and multiple myeloma: An urgent unmet need.
Yasmine St Martin, Joseph K Franz, Mounzer E Agha, Hillard M Lazarus

Blood Rev· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No needles needed: All-oral therapy options for relapsed and refractory multiple myeloma.
Joseph Franz, Elizabeth Myrus, Larysa Sanchez, Joshua Richter

Blood Rev· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis.
Kainat Saleem, Joseph Franz, Mary Lou Klem, Jonathan G Yabes, Michael Boyiadzis

Lancet Haematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory drug- and proteasome inhibitor-backbone regimens in the treatment of relapsed multiple myeloma: an evidence-based review.
Larysa Sanchez, Kevin Barley, Joshua Richter, Joseph Franz, Hearn Jay Cho

Expert Rev Hematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strict sequestration versus lenient isolation precautions during hematopoietic stem cell transplant: results of a quality initiative.
Joseph K Franz, Alexander R Coltoff, Amir S Steinberg

Infect Control Hosp Epidemiol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Human IL-22 Receptor Is Regulated through the Action of the Novel E3 Ligase Subunit FBXW12, Which Functions as an Epithelial Growth Suppressor.
Joseph Franz, Jacob Jerome, Travis Lear, Qiaoke Gong, Nathaniel M Weathington

J Immunol Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis